MENU
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Empowering Life Sciences for Blooming Life
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Profile
  • Blog
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. cardiovascular

cardiovascular– tag –

  • Biotech Investment

    Biotech Investment News: Key Pharmaceutical Deals of Otsuka (2015–2025)

    Strategic Overview: Otsuka’s Global Expansion in CNS and Rare Diseases Otsuka Pharmaceutical has focused heavily on the central nervous system (CNS), leveraging U.S.-centered M&A and partnerships to expand its product pipeline. In re...
    2025-07-02
  • Biotech Investment

    Biotech Investment News: Novartis’s Key Deals from 2015 to 2025

    Strategic Review: From Blockbusters to Nuclear Medicine, Gene and Cell Therapy Over the past decade, Novartis has strategically shifted its focus toward high-value therapies, including nuclear medicine (Pluvicto), gene therapy (Zolgensma...
    2025-06-29
  • Biotech Investment

    Biotech Investment News: Bristol Myers Squibb’s Major Deals (2015–2025)

    Strategic Review: From Opdivo to Next-Gen Modalities BMS is known as a pioneer in immuno-oncology, with the development of Opdivo (nivolumab) and Yervoy (ipilimumab). Over the past decade, the company has expanded aggressively into new m...
    2025-06-27
  • Biotech Investment

    Biotech Investment News: Johnson & Johnson’s 10-Year Deal Summary & 2025 Update (2015–2025)

    Strategic Review: Immunology, Oncology, and Rare Diseases at the Core of J&J’s R&D-Driven Vision Johnson & Johnson (J&J) has strategically expanded into immunology, oncology, and rare diseases by acquiring biotech compani...
    2025-06-26
1
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English